Abstract
The correct diagnosis of sleep disorders in Parkinson’s Disease (PD) patients consists in: detailed anamnesis of the patient and of the spouse or of the caregiver; 1 week recording on a symptom diary (log) by the patient or the caregiver; pointing out the co-morbidities and selection of the most appropriate sleep test such as: polysomnography, multiple sleep latency test, multiple wake latency test, Epworth Sleepiness Scale, actigraphy, or video-PSG. The sleep-arousal disturbances considered by the present article, in order to achieve a better quality of life for Parkinson’s disease patients are: light fragmented sleep; abnormal motor activity during sleep; REM behavior disorders; sleep related breathing disorders; sleep related hallucinations; sleep related psychotic behavior. The arousal disturbances to be described are: sleep attacks, and excessive daytime sleepiness.
Similar content being viewed by others
References
Askenasy JJM. Sleep patterns in extrapyramidal disorders. Int. J. Neurol. 1981; 15: 62–76.
Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinson’s disease. Mov. Disord. 1998; 13: 895–9.
Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep Disorders and sleep effect in Parkinson’s disease. Mov. Disord. 1990; 5: 280–5.
Lees AJ, Blackburn NA, Campbell V. The nighttime problems of Parkinson’s disease. Clin. Neuropharmacol. 1998; 11: 512–19.
Rao ML, Clarenbach P, Vahlensieck M, Kratzschmar S. Gabapentin augments whole blood serotonin in healthy young man. J. Neural. Transm. 1988; 73: 129–34.
Horiguchi J, Inami Y, Nishimatsu O et al. Sleep-wake complaints in Parkinson’s disease. Rinsho Shinkeigaku 1990; 30: 214–16. (In Japanese).
van Hilten JJ, Weggeman M, van der Velde EA et al. Sleep, excessive daytime sleepiness and fatigue in Parkinson’s disease. J. Neural. Transm. Park. Dis. Dement. Sect. 1993; 5: 235–44.
van Hilten B, Hoff JI, Middelkoop HA et al. Sleep disruption in Parkinson’s disease. Assessment by continuous activity monitoring. Arch. Neurol. 1994; 51: 922–8.
Nakamuro T, Futamura N, Murata K et al. Screaming during sleep in Parkinson’s disease. Rinsho Shinkeigaku 1998; 38: 457–60. (In Japanese).
Laihinen A, Alihanka J, Raitasuo S, Rinne UK. Sleep movements and associated autonomic nervous acivities in patients with Parkinson’s disease. Acta Neurol. Scand. 1987; 76: 64–8.
Apps MC, Sheaff PC, Ingram DA et al. Respiration and sleep in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 1985; 48: 1240–5.
Feinsilver SH, Friedman JH, Rosen JM. Respiration and sleep in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 1986; 49: 964.
Partinen M. Sleep disorder related to Parkinson’s disease. J. Neurol. 1997; 244: S3–6.
Trenkwalder C. Sleep dysfunction in Parkinson’s disease. Clin. Neurosci. 1998; 5: 107–14.
Butler RN, Davis R, Lewis CB et al. Physical fitness; benefits of exercise for the older patient. Geriatrics 1998; 53: 46–9.
MacMahon DG. Parkinson’s disease nurse specialists: an important role in disease management. Neurology 1999; 52: S21–5.
Chesson AL, Wise M, Davila D et al. Practice Parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 1999; 22: 961–8.
Chabli A, Michaud M, Montplaisir J. Peridic arm movements in patients with restless legs syndrome. Eur. Neurol. 2000; 4: 133–8.
Wetter TC, Collado-Seidel V, Pollmacher T, Yassouridis A, Trenkwalder C. Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy. Sleep 2000; 23: 361–7.
Askenasy JJ, Yahr MD. Reversal of sleep disturbance in Parkinson’s disease by antiparkinsonian therapy: a preliminary study. Neurology 1985; 35: 527–32.
Lang AE. Restless leg syndrome and Parkinson’s disease: insights into pathophysiology. Clin. Neuropharmacol. 1987; 10: 476–8.
Linazasoro G, Masso JFM, Suarez JA. Nocturnal akathisia in Parkinson’s disease: treatment with clozapine. Mov. Disord. 1993; 8: 171–4.
Montplaisir J, Godbout R, Pelletier G, Warnes H. Restless leg syndrome and periodic leg movements during sleep. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. W.B. Sauders Co: Philadelphia, 2000; 742–52.
Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic, and generic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov. Disord. 1997; 12: 61–5.
Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1993; 17: 739–43.
Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs syndromes in adults. Arch. Intern. Med. 2000; 160: 2137.
Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology 2000; 54: 1064–8.
Rye DB, Bliwise DL. Movement disorders specific to sleep and the nocturnal manifestations of waking movement disorders. In: Watts RL, Koller WC, eds. Movement Disorders: Neurologic Principles and Practice. Mc Graw-Hill: New York, 1997; 687–713.
Askenasy JJM, Yahr MD. Different laws govern motor activity in sleep than in wakefulness. J. Neural. Transm. 1990; 79: 103–11.
Askenasy JJM, Weitzman ED, Yahr MD. Are periodic movements in sleep a basal ganglia dysfunction? J. Neural. Transm. 1985; 70: 337–48.
Watanabe S, Sakai K, Ono Y, Seino H, Naito H. Alternating periodic leg movements induced by spinal anesthesia in an elderly male. Anaesth. Analg. 1987; 66: 1031–2.
Yokota T, Hirose K, Tanabe H et al. Sleep related periodic leg movements (nocturnal myoclonus) due to spinal cord lesion. J. Neurol. Sci. 1991; 104: 13–18.
Bucher SF, Seelos KC, Oertel WH, Reiser M, Trenkwalder C. Cerebral generators involved in pathogenesis of the restless legs syndrome. Ann. Neurol. 1997; 53: 46–9.
Brodeur C, Montplaisir J, Godbout R et al. Treatment of restless legs syndrome and periodic leg movements during sleep with L-dopa: a double blind, controlled study. Neurology 1988; 38: 1845–8.
Wetter TC, Stiansky K, Winkelmann J et al. A randomized, controlled study of pergolide in patients with restless legs syndrome. Neurology 1999; 52: 944–50.
Wetter TC, Pollmacher T. Restless legs and periodic leg movements in sleep syndromes. J. Neurol. 1997; 244 (4 Suppl 1): S37–45.
Reuter I, Ellis CM, Ray Chaudhuri K. Nocturnal subcutaneous apomorphine infusion in Parkinson’s disease and restless legs syndrome. Acta Neurol. Scand. 1999; 100: 163–7.
Ancoli-Israel S, Kripke D, Klauber M et al. Periodic Leg Movements in sleep in community dwelling elderly. Sleep 1991; 14: 496–500.
Morrison AR, Bowker RM. The biological significance of PGO spikes in the sleeping cat. Acta Neurobiol. Exp. 1975; 35: 821–40.
Chase MH, Morales FR. Phasic changes in motoneuron membrane potential during REM periods of active sleep. Neurosci. Lett. 1982; 34: 177–82.
Siegel JM. Pontomedullary interactions in the generation of REM sleep. In: McGinty DJ, Drucker-Collin R, Morrison A, Parmeggiani PL, eds. Brain Mechanisms of Sleep. Raven Press: New York, 1985; 157–74.
Montplaisir J, Godbout R, Poirier G, Bedard MA. Restless legs syndrome and periodic movements in sleep: physiopathology and treatment with L-dopa. Clin. Neuropharmacol. 1986; 9: 456–63.
Parkinson J. Essay on the Shaking Palsy. Sherwood Nealy & Jones: London, 1817.
Gowers WR. A Manual of Diseases of the Nervous System. Blakiston: Philadelphia, 1901.
Brain R. Clinical Neurology. Oxford University Press: London, 1964.
Askenasy JJM. Sleep in Parkinson’s disease. Acta Neurol. Scand. 1993; 87: 167–70.
Askenasy JJM. Approaching disturbed sleep in late Parkinson’s disease: first step toward a proposal for a revised UPDRS. Parkinsonism Relat. Disord. 2001; 8: 123–31.
April RS. Observations on Parkinsonian tremor in all-night sleep. Neurology 1996; 16: 720–4.
Tassinari CA, Broughton R, Poire R. An electro-clinical study of nocturnal sleep in patients presenting abnormal movements. Electroencephalogr. Clin. Neurophysiol. 1965; 18: 95.
Aldrich MS. Parkinsonism. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. Saunders Co.: Philadelphia, 2000; 1051–7.
Hening WA, Walters AS, Chokroverty S. Motor functions and dysfunctions of sleep. In: Chokroverty S, ed. Sleep Disorders Medicine. Butterworth-Heinemann: Boston, London, Oxford, Singapore, Sydney, Toronto, Wellington, 1995; 265–6.
Hishikawa Y. Proceedings: abnormalities of REM sleep in narcoleptics and in acute alcohol psychotics. Electroencephalogr. Clin. Neurophysiol. 1975; 39: 542–3.
Schenck CH, Bundlie SR, Patterson AL, Mahowald MW. Rapid eye movement sleep Behavior disorder: a treatable parasomnia affecting older adults. J. Am. Med. Assoc. 1987; 257: 1786–9.
Thorpy MJ, Yager J eds. The Enciclopedia of Sleep and Sleep Disorders. Facts on File: New York, Oxford, 1991.
Comella CL, Ristanovic R, Goetz CG. Parkinson’s disease patients with and without REM behavior disorder (RBD): a polysomno-graphic and clinical comparison. Neurology 1993; 43 (Suppl 2): A301.
Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 1996; 46: 388–93.
Olsen EJ, Boewe BF, Silber MH. Rapid eye movements sleep behavior disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000; 123: 331–9.
Comella CL, Nardine TM, Diederich NJ, Stebbins GT. Sleep related violence, injury, and REM sleep behavior disorders in multiple system atrophy. Neurology 1998; 51: 526–9.
Shimizu T, Sugita Y, Teshima Y, Hishikawa Y. Sleep study in patients with spinocerebellar degeneration and related disease. In: Koella WP, ed. Sleep. Karger: Basel, 1981; 435–7.
Comella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinson’s disease patients with treatment-induced hallucinations. Ann. Neurol. 1993; 34: 710–14.
Uchiyama M, Isse K, Tanaka K. Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology 1995; 45: 709–12.
Tan A, Salgado M, Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson’s disease with therapeutic response to levodopa. Mov. Disord. 1996; 11: 214–16.
Silber MH, Ahlskog JE. REM sleep behavior disorder in parkinsonian syndromes. Sleep Res. 1992; 21–2.
Negro PJJ, Faber R. Lewy body disease in a patient with REM sleep disorder. Neurology 1996; 46: 1493.
Turner RS, Chervin RD, Frey KA et al. Probable diffuse Lewy body disease presenting as REM sleep behavior disorder. Neurology 1997; 49: 523–7.
Plazzi G, Corsini R, Provini F et al. REM sleep behavior disorders in multiple system atrophy. Neurology 1997; 48: 1094–7.
Sforza E, Krieger J, Petiau C. REM sleep behavior disorder and psychopathological findings. Sleep Med. Rev. 1997; 1: 57–69.
Boeve BF, Silber MH, Ferman TJ et al. REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease. Neurology 1998; 51: 363–70.
Schenck CH, Mahowald MW. Polysomnographic, neurologic, psychiatric, and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD). Cleve. Clin. J. Med. 1990; 57: S9–23.
Jouvet M, Delorme JF. Locus coeruleus et sommeil paradoxal. C. R. Soc. Biol. 1965; 159: 859–99. (In French).
Pompeiano O. Mechanisms responsible for spinal inhibition during desynchronized sleep: experimental study. In: Guilleminault C, Dement WC, Passuant P, eds. Advances in Sleep Research, Vol. 13. WB Saunders: Philadelphia, 1976; 411–21.
Sakai K, Sastre JP, Danamori N. Specific neurons in the ponto-medulary reticular formation with special references to the postural atonia during paradoxical sleep in the cat. In: Pompeiano O, Marsen CA, eds. Brain Mechanism of Perceptual Awareness and Purposal Behavior. Raven Press: New York, 1981; 405–10.
Eisensehr I, Linke R, Noachtar S, Schwartz J, Gildehaus FJ, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behavior disorder. Comparison with Parkinson’s disease and controls. Brain 2000; 123: 1155–60.
Albin RL, Koeppe RA, Cervin RD et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 2000; 55: 1410–12.
Bejjani BP, Houeto JL, Hariz M et al. Aggressive Behavior induced by intraoperative stimulation in the triangle of Sano. Neurology 2002; 59: 1425–7.
Schenck CH, Hurwitz TD, Mahowald MW. Symposium: normal and abnormal REM sleep egulation: REM sleep behavior disorder: an update of a series of 96 patients and a review of the world literature. J. Sleep Res. 1993; 2: 224–31.
Micek ST, Ernst ME. Tolcapone. a novel approach to Parkinson’s disease. Am. J. Health Syst. Pharm. 1999; 56: 2195–205.
Perry TL, Wright JM, Berry K et al. Dominantly inherited apathy, central hypoventilation, and Parkinson’s syndrome: clinical, biochemical, and neuropathological studies of 2 new cases. Neurology 1990; 40: 1882–7.
Katz DM, Balkowiec A. New insights into the ontogeny of breathing from genetically engineered mice. Curr. Opin. Pulm. Med. 1997; 3: 433–9.
Balkowiec A, Katz DM. Brain-derived neurotrophic factor is required for normal development of the central respiratory rhythm in mice. J. Physiol. 1998; 510: 527–33.
Pang PT, Teng HK, Zaitsev E et al. Cleavage of proBDNF by tPA/Plasmin is essential for long-term hippocampal plasticity. Science 2004; 306: 487–91.
Manford M, Andermann F. Complex visual hallucinations. Clinical and neurobiological insights. Brain 1998; 121: 1819–40.
Fenelon G, Mahieux F, Huon R, Ziegler M. Hallucinations in Parkinson’s disease: prevalence, phenomenology and risk factors. Brain 2000; 123: 733–45.
Houeta JL, Arnulf I. Troubles psychiques et somnolence. Rev. Neurol. 2002; 158: S102–7. (In French).
Moskovitz C, Moses K, Klawans HL. Levodopainduced psychosis: a kindling phenomenon. Am. J. Psychiatry. 1978; 135: 669–75.
Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson’s disease. Arch. Neurol. 1996; 53: 1265–8.
Arnulf I, Bonnet AM, Damier P et al. Hallucinations, REM sleep and Parkinson’s disease. Neurology 2000; 55: 281–8.
Sharf B, Moskovitz C, Lupton MD, Klawans HL. Dream phenomena induced by chronic levodopa therapy. J. Neural. Transm. 1978; 43: 143–51.
Pappert EJ, Goetz CG, Niedermann FG et al. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson’s disease. Mov. Disord. 1999; 14: 117–21.
Nausidea PA, Weiner WJ, Kaplan LR, Weber S, Klawans HL. Sleep disruption in the course of chronic levodopa therapy; an early feature of the levodopa psychosis. Clin. Neuropharmacol. 1982; 5: 183–94.
Frucht SJ, Bernsohn L. Visual hallucinations in PD. Neurology 2002; 59: 1965.
Friedman JH. Behavioral dysfunction in Parkinson’s disease. Clin. Neurosci. 1998; 5: 87–93.
Juncus JL. Management of psychotic aspects of Parkinson’s disease. J. Clin. Psychiatry 1999; 60 (Suppl 8): 42–53.
Stoppe G, Brandt CA, Staedt JH. Behavioural problems associated with dementia: the role of newer antipsychotics. Drug Aging 1999; 14: 4154.
Valldeoriola F, Molinuevo J. Therapy of behavioral disorders in Parkinson’s disease. Biomed. Pharmacother. 1999; 53: 149–53.
Menza MA, Rosen RC. Sleep in Parkinson’s disease. The role of depression and anxiety. Psychosomatics 1995; 36: 262–6.
Starkstein SE, Preziosi TJ, Robinson RG. Sleep disorders, pain, and depression in Parkinson’s disease. Eur. Neurol. 1991; 31: 352–5.
Dooneief G, Mirabello E, Bell K et al. An estimate of the incidence of depression in idiopathic Parkinson’s disease. Arch. Neurol. 1992; 49: 305–7.
Demet EM, Chicz-Demet A, Fallon JH, Sokolski KN. Sleep deprivation therapy in depressive illness and Parkinson’s disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 1999; 23: 753–84.
Kostic VS, Susic V, Covickovic-Sternic N et al. Reduced rapid eye movements sleep latency in patients with Parkinson’s disease. J. Neurol. 1989; 236: 421–3.
Henderson R, Kurlan R, Kersum JM, Como P. Preliminary examination of the co-morbidity of anxiety and depression in Parkinson’s disease. J. Neuropsychiatry Clin. Neurosci. 1992; 4: 257–64.
Schapira AH. Sleep attacks (sleep episodes) with pergolide. Lancet 2000; 355: 1332–3.
Ferreira JJ, Galitzky M, Montastruc JL, Rascol O. Sleep attacks and Parkinson’s disease treatment. Lancet 2000; 355: 1333–4.
Whitney CW, Enright PL, Newman AB et al. Correlates of daytime sleepiness in 4578 elderly persons: the cardiovascular healts study. Sleep 1998; 21: 27–36.
Askenasy JJM, Yahr MD. Suppression of REM rebound by pergolide. J. Neural. Transm. 1984; 59: 151–9.
Morewitz JH. Evaluation of excessive daytime sleepiness in the elderly. J. Am. Geriatr. Soc. 1988; 36: 324–39.
Carskaden MA. Sleep and Alertness. Raven Press: New York, 1989; 53–69.
Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson’s disease: a community-based study. Mov. Disord. 1999; 14: 922–7.
Smith MC, Ellgring H, Oertel WH. Sleep disturbances on Parkinson’s disease patients and spouses. J. Am. Geriatr. Soc. 1997; 45: 194–9.
El-Ad B, Korczyn AD. Disorders of excessive daytime sleepiness-an update. J. Neurol. Sci. 1998; 153: 192–202.
Rye DB, Bliwise DL, Dihenia B, Gurecki P. Daytime sleepiness in Parkinson’s disease. J. Sleep Res. 2000; 9: 63–9.
Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea: the Epworth sleepiness scale. Chest 1993; 103: 30–6.
Johns MW. Sleepiness in different situations measured by the Epworth Sleepiness scale. Sleep 1994; 17: 703–10.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Askenasy, JJ. Trying to understand sleep in Parkinson’s disease patients. Sleep Biol. Rhythms 3, 2–14 (2005). https://doi.org/10.1111/j.1479-8425.2005.00156.x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1111/j.1479-8425.2005.00156.x